- Novartis Hid Manipulated Data While Seeking Approval for $2.1 Million Treatment—The failure to report the issue has not put patients at risk, the F.D.A. said, but the drugmaker could face criminal and civil penalties. https://www.nytimes.com/2019/08/06/health/novartis-fda-gene-therapy.html 10 comments politics
Linking pages
Related searches:
Search whole site: site:nytimes.com
Search title: Novartis Hid Manipulated Data While Seeking Approval for $2.1 Million Treatment - The New York Times
See how to search.